Glass syringe maker Schott Pharma expands its US footprint with $371M site in North Carolina
Glass syringe maker Schott Pharma expands its US footprint with $371M site in North Carolina zbecker Mon, 03/18/2024 - 16:57
Glass syringe maker Schott Pharma expands its US footprint with $371M site in North Carolina zbecker Mon, 03/18/2024 - 16:57
After Kyowa Kirin buyout, Orchard scores FDA approval for first MLD gene therapy in the US fkansteiner Mon, 03/18/2024 - 15:10
Bluebird bio secures loan lifeline from Hercules Capital to help support 3 gene therapy launches zbecker Mon, 03/18/2024 - 11:16
Pfizer set to collect roughly $2.6B in sell-off of Haleon shares, reducing stake from 32% to 24% kdunleavy Mon, 03/18/2024 - 11:09
Following Boehringer's lead, AstraZeneca caps monthly out-of-pocket inhaler costs at $35 in the US fkansteiner Mon, 03/18/2024 - 10:38
AstraZeneca, GSK make case for broad immunotherapy uses in endometrial cancer. But questions remain aliu Mon, 03/18/2024 - 10:30
W.R. Grace debuts expanded operations at Michigan API facility jkeenan Mon, 03/18/2024 - 10:18
BMS-backed radiopharma specialist Ratio expands manufacturing deal with CDMO PharmaLogic kdunleavy Mon, 03/18/2024 - 08:33